Skip to main content
Journal ArticleOPEN ACCESS

Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation

  • Imashuku S
  • Kudo
  • Kubo
  • et al.
Journal of Blood Medicine (2012) 157
DOI: 10.2147/jbm.s37631
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Acquired hemophilia A is rarely found in association with myeloproliferative neoplasms, such as the JAK2 kinase V617F mutation-positive chronic neutrophilic leukemia (CNL).

Cite

CITATION STYLE

APA

Imashuku, S., Kudo, Kubo, Saigo, Okuno, & Tohyama. (2012). Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation. Journal of Blood Medicine, 157. https://doi.org/10.2147/jbm.s37631

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free